STAT6 and neoplasm: For example, treatment with anthracyclines and oxaliplatin results in immunogenic tumor cell death and platinum-based chemotherapeutics downregulate the inhibitory STAT6/PD-L2 pathway and sensitize tumor cells for T cell-mediated cytotoxicity [3]–[5].